Sudan renews medtech prospects:
This article was originally published in Clinica
Executive Summary
International healthcare efforts in the Darfur region of Sudan are set to resume, after the government signed a series of security and humanitarian access agreements yesterday. The move is in response to widespread condemnation of the severe social instability in the region. The situation has essentially obviated the calls made in July to meet shortfalls in medical supplies and diagnostic services and hospital infrastructures (see Clinica No 1117, p 13). International efforts were expected to resume last week, after the government signed a series of security and humanitarian access agreements, in response to widespread condemnation of the severe social instability in the region. The UN Security Council met on November 18, in Nairobi, Kenya, to discuss the situation and consider sanctions.
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.